Morgan Stanley Upgrades Illumina To Overweight

Analysts at Morgan Stanley upgraded

from Equal-weight to Overweight. The price target for Illumina has been lowered from $190.00 to $162.00. Illumina shares have gained 28.33 percent over the past 52 weeks, while the S&P 500 index has surged 12.33 percent in the same period. Illumina shares climbed 0.26 percent to $202.50 in pre-market trading.